- CEO
- Zhi Shan Yang
- Full Time Employees
- 1,712
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- No.112 Qinhuang West Street Qinhuangdao HE China 066004
- IPO Date
- Aug 24, 2020
- Business
- Contec Medical Systems Co., Ltd. (300869.SZ) researches, develops, manufactures, and sells medical diagnosis and monitoring equipment. The company offers a broad portfolio of products across more than 20 categories, including pulse oximeters; sphygmomanometers and blood pressure monitors; electrocardiograph systems such as resting ECG, dynamic ECG, and stress ECG; patient monitors and central monitoring systems; ultrasound equipment encompassing B ultrasound, color Doppler ultrasound, and pocket fetal Doppler; endoscopes and camera systems; in vitro diagnostics like semi-automatic and automatic biochemistry analyzers, hematology analyzers, urine analyzers, and POCT devices; EEG and EMG systems; infusion and syringe pumps; respiratory aids including oxygen concentrators; telemedicine solutions; veterinary equipment; stethoscopes; thermometers; sleep and snoring aids; massagers; simulators; and related accessories. These products serve medical institutions, clinics, household users, and veterinary applications, with sales through distributors in over 130 countries and regions worldwide.
Founded in 1996 and headquartered in Qinhuangdao, Hebei Province, China, the company operates as a high-tech enterprise with a production base spanning over 67,450 square meters and more than 1,000 employees. It maintains subsidiaries including Contec Medical Systems USA Inc. in Chicago (established 2012), Contec Medical Systems India Pvt Ltd. in New Delhi (2019), and Contec Medical Systems Germany GmbH in Dusseldorf (2019), supporting its international expansion. [aboutus page] Products hold certifications such as CE, FDA, and approvals from Canada, Japan, and Brazil.
In recent years, Contec listed on the Shenzhen Stock Exchange in August 2020 (stock code: 300869), marking a key milestone for capital access and growth. [aboutus page] The company initiated a major production base expansion project in February 2021, covering 38,318.82 square meters with a total investment of 219.2725 million yuan to enhance manufacturing capacity, industrial optimization, and employment. [newsinfo/496094.html] It continues pursuing market expansions into Southeast Asia and Europe with an expected 15% CAGR, alongside strategic acquisitions enabled by cash reserves and a recent 500 million yuan debt issuance rated BBB to fund R&D and production upgrades.